metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Risk factors for major complications after surgical treatment of primary ileocec...
Información de la revista
Vol. 101. Núm. 12.
Páginas 824-832 (diciembre 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
149
Vol. 101. Núm. 12.
Páginas 824-832 (diciembre 2023)
Original article
Acceso a texto completo
Risk factors for major complications after surgical treatment of primary ileocecal Crohn's disease. A multicenter Latin American experience
Factores de riesgo para complicaciones mayores posteriores al tratamiento quirúrgico de la enfermedad de Crohn con afectación ileocecal. Trabajo retrospectivo, multicéntrico en América Latina
Visitas
149
SURGICAL IBD LATAM CONSORTIUM , Nicolás Avellanedaa,b,
Autor para correspondencia
n.avellaneda86@gmail.com

Corresponding author.
, Claudio Saddy Rodrigues Coyc, Henrique Sarubbi Fillmannd, Rogerio Saad-Hossnee, Juan Pablo Muñozf, Rafael García-Duperlyg, Felipe Bellolioh, Nicolás Rotholtzi, Gustavo Rossij, Juan Ricardo Marquez Vk, Mariano Cillol, Antonio Lacerda-Filhom, Augusto Carriea, Beatriz Yuki Maruyaman, Lucio Sarubbi Fillmannd, Marcela Maria Silvino Craveiroe, Ezequiel Ferrof, Eduardo Londoño-Schimmerg, Andrés Iglesiash..., Camila Bras Harriotti, Juan Pablo Campanaj, Daniel Londoño Estradam, Rogini Balachandranb, Paulo Gustavo KotzenVer más
a General Surgery Department, Hospital Universitario CEMIC, Argentina
b Colorectal Surgery Department, Aarhus University Hospital, Denmark
c Colorectal Surgery Unit, Campinas State University (UNICAMP), Campinas, Brazil
d Surgery Department, Pontificia Universidad Católica de Rio Grande do Sul, Brazil
e Colorectal Surgery Department, Paulista State University UNESP, Brazil
f Colorectal Surgery Department, Nueva Proctología, Argentina
g Colorectal Surgery Department, Fundación Santa Fé de Bogotá, Colombia
h Coloproctology Unit, Digestive Surgery Department, Pontíficia Universidad Católica de Chile, Chile
i Colorectal Surgery Service, General Surgery Department, Hospital Aleman de Buenos Aires, Argentina
j Section of Colorectal Surgery, Department of General Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
k Coloproctology Institute, Clínica Las Américas, Colombia
l Colorectal Surgery Department, Hospital Británico de Buenos Aires, Argentina
m Department of Colorectal Surgery, Felicio Rocho Hospital, Belo Horizonte, Brazil
n Colorectal Surgery Unit, Pontificia Universidade Católica do Paraná (PUCPR), Curitiba, Brazil
Ver más
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (2)
Tablas (4)
Table 1. Preoperative variables.
Table 2. Intraoperative variables.
Table 3. Postoperative variables.
Table 4. Multivariate analysis.
Mostrar másMostrar menos
Material adicional (1)
Abstract
Introduction

Complications after ileocecal resection for Crohn's disease (CD) are frequent. The aim of this study was to analyze risk factors for postoperative complications after these procedures.

Materials and methods

We conducted a retrospective analysis of patients treated surgically for Crohn's disease limited to the ileocecal region during an 8-year period at 10 medical centers specialized in inflammatory bowel disease (IBD) in Latin America. Patients were allocated into 2 groups: those who presented major postoperative complications (Clavien-Dindo>II), the “postoperative complication” (POC) group; and those who did not, the “no postoperative complication” (NPOC) group. Preoperative characteristics and intraoperative variables were analyzed to identify possible factors for POC.

Results

In total, 337 patients were included, with 51 (15.13%) in the POC cohort. Smoking was more prevalent among the POC patients (31.37 vs 17.83; p=0.026), who presented more preoperative anemia (33.33 vs 17.48%; p=0.009), required more urgent care (37.25 vs 22.38; p=0.023), and had lower albumin levels. Complicated disease was associated with higher postoperative morbidity. POC patients had a longer operative time (188.77 vs 143.86min; p=0.005), more intraoperative complications (17.65 vs 4.55%; p<0.001), and lower rates of primary anastomosis. In the multivariate analysis, both smoking and intraoperative complications were independently associated with the occurrence of major postoperative complications.

Conclusion

This study shows that risk factors for complications after primary ileocecal resections for Crohn's disease in Latin America are similar to those reported elsewhere. Future efforts in the region should be aimed at improving these outcomes by controlling some of the identified factors.

Keywords:
Crohn
Ileocecal
Resection
IBD
Risk
Complication
Resumen
Introducción

Las complicaciones posteriores a resección ileocecal por enfermedad de Crohn (EC) son frecuentes. El objetivo de este estudio fue analizar los factores de riesgo para presentar complicaciones postoperatorias después de estos procedimientos.

Materiales y métodos

Se realizó un análisis retrospectivo de los pacientes operados por EC limitada a la región ileocecal durante un período de 8 años en 10 centros especializados en enfermedad inflamatoria intestinal (EII) de América Latina. Los pacientes fueron divididos en 2 grupos, los que presentaron complicaciones postoperatorias mayores (Clavien-Dindo>II) (denominado grupo de complicaciones postoperatorias [POC]) y los que no (grupo sin complicaciones postoperatorias [NPOC]). Se analizaron las características preoperatorias y las variables intraoperatorias para identificar posibles factores relacionados con las POC.

Resultados

Se incluyeron 337 pacientes, 51 (15,13%) en el grupo con POC. El grupo POC presentó mayor índice de tabaquismo (31,37 vs. 17,83; p=0,026), quienes presentaron más anemia preoperatoria (33,33 vs. 17,48%; p=0,009), urgencias (37,25 vs. 22,38; p=0,023) y menores niveles de albúmina. Los procedimientos por enfermedad complicada se asociaron con una mayor morbilidad postoperatoria. Los pacientes con POC tuvieron un tiempo operatorio más largo (188,77 vs. 143,86min; p=0,005), más complicaciones intraoperatorias (17,65 vs. 4,55%; p<0,001) y menores tasas de anastomosis primaria. En el análisis multivariado, tanto tabaquismo como complicaciones intraoperatorias se asociaron de forma independiente con la aparición de complicaciones mayores postoperatorias.

Conclusión

Este estudio demuestra que los factores de riesgo de complicaciones posteriores a resecciones ileocecales primarias por EC en América Latina son similares a los reportados en otros lugares. Los esfuerzos futuros en la región deben estar dirigidos a mejorar estos resultados mediante el control de algunos de los factores identificados.

Palabras clave:
Crohn
Ileocecal
Resección
EII
Riesgo
Complicación
Texto completo
Introduction

Crohn's disease (CD) is a chronic condition associated with transmural inflammation, which commonly affects the ileocaecal region.1 In these patients, repeated flares of the disease are associated with complications (fibrotic stenosis or fistulas), and despite significant advances in medical therapy, surgery is still needed in a significant proportion of patients.2

In Latin America, as in other parts of the world, the prevalence of Crohn's disease is rising, with some of the highest numbers reported in Brazil and Argentina, of approximately 24 and 15 patients/100,000 persons.3

Ileocaecal resections for complicated disease are associated with higher rates of postoperative complications, when compared to luminal disease.4,5 For this reason, different studies aimed to identify risk factors associated with higher postoperative morbidity.6

Data related to the surgical management of inflammatory bowel disease (IBD) in Latin America is scarce. Information about indications and outcomes of ileocaecal resections for CD, use of minimally invasive approach and types of anastomosis, as examples, are lacking.7

The aim of this study was to identify possible risk factors associated with postoperative complications in a large cohort of patients submitted to primary ileocaecal resections due to CD in different countries in Latin America.

Materials and methodsEthical considerations

This study was approved by institutional review boards from all included centers, according to good clinical practice standards.

Study design and setting

This is a retrospective multicentric study. Consecutive patients primarily operated for CD, limited to the ileocaecal region, from ten IBD specialized, academic centers of 4 countries from Latin America (Argentina, Brazil, Chile and Colombia), during a 8-year period (2012–2020), were identified and included in the study.

A first analysis on this cohort was performed comparing outcomes of patients operated on for luminal affection only or for complications of the disease.8

Participants

Inclusion criteria: Patients submitted to primary ileocaecal resections due to CD, by conventional or laparoscopic approach, with luminal, stenotic or penetrating phenotypes.

Exclusion criteria: Previous abdominal procedures related to CD, missing data in electronic charts, and age younger than 18 years old.

Patient stratification

Patients were allocated into 2 groups, according to the presence of major postoperative complications (Clavien-Dindo>II)9 within 30 days from the procedure (POC: with complications, NPOC: without complications).

Data collection and management

Information regarding patients’ comorbidities and operative procedures were collected in an electronic database, which was validated by three experts in colorectal surgery and biostatistics to identify key issues and to maximize completeness and accuracy of data. Local investigators fulfilled their specific databases, which were combined by the primary author (NA). The lead investigators (NA and PGK) checked the accuracy of all cases to ensure data quality. When missing data were identified, the local lead investigator was contacted and asked to complete the records.

Variables analyzed

Preoperative variables included patients’ demographics (comorbidities stratified by Charlson's comorbidity score), smoking status, preoperative anemia and albumin levels, ASA score and history of previous abdominal procedures.

Variables associated to Crohn's disease included time from CD diagnosis to surgery (disease duration), Montreal classification, exposure to biological agents before surgery and within 12 weeks of the operative procedure, history of perianal disease, previous exposure to corticosteroids at the time of surgery (defined as receiving more than 20mg/day of Prednisolone for more than 6 weeks),10 and requirement of preoperative nutritional optimization before the procedure (defined as patients who needed to be hospitalized in order to receive enteral or parenteral nutrition before surgery). Proportions of early surgery (for luminal affection as defined by Maruyama et al.)11 or surgery for complications of the disease (stenoses or fistulas) were also evaluated.

Intraoperative factors included operative time, character of surgery (urgent or elective), operative approach and conversion rate, presence of intraoperative complications and their respective stratification according to CLASSIC Classification,12 requirements of associated procedures and rates of primary anastomosis. Decisions regarding the specific type of anastomosis and management of the colonic stump in patients who did not receive an anastomosis were also considered between the 2 groups.

Postoperative factors included length of hospitalization, readmission, reoperation rates, and mortality within 30 days of the procedure.

Outcomes

The main outcome of the study was to compare preoperative and intraoperative characteristics between POC and NPOC groups, aiming for identification of possible risk factors associated with 30-day postoperative major complications.

Statistical analysis

Statistical analysis was performed using Stata Software (v11.1, Statacorp, College Station, Texas, USA). The categorical variables were described as percentages whereas numerical variables were described as mean or median (accordingly) with their range. The normality of each numerical variable was evaluated visually and with the Kolmogorov–Smirnov test.

We used the chi square or Fisher exact tests, as appropriate, for the comparison of categorical variables, and the Student's T or Fisher's exact test for continuous variables. OR with respective 95% CI were also calculated.

A multivariable analysis using a logistic regression model was performed including all the variables compared with a p value of less than 0.05 and those variables considered clinically significant by the investigators. A p value below 0.05 was considered statistically significant. Our primary outcome variable was the presence of major postoperative complications.

Results

Overall, 337 patients met the inclusion criteria, of which 51 (15.13%) presented major complications and comprised the POC group. Fig. 1 describes the patient selection process, and Appendix 1 describes the number of patients included per center.

Fig. 1.

Patient selection process.

(0.41MB).
Preoperative variables

Information of included patients prior to surgery are described in detail in Table 1. No differences between POC and NPOC groups were identified in relation to sex, Charlson comorbidity score, other comorbidities, ASA score, previous abdominal procedures, and time from CD diagnosis to surgery.

Table 1.

Preoperative variables.

Variables  All patientsN=337 (100%)  NPOCN=286 (84.87%)  POCN=51 (15.13%)  p value  OR (95% CI) 
Sex (female)  177 (52.52)  154 (53.85)  23 (45.10)  0.249  0.70 (0.39–1.28) 
Age (median, range)  39.78 (18–89)  39.16 (18–89)  43.22 (18–77)  0.095   
Smoking  67 (19.88)  51 (17.83)  16 (31.37)  0.026  2.11 (1.08–4.12) 
BMI (median, 95% CI)  22.87 (13.96 0 37)  23.09 (14.84–37)  21.70 (13.96–30.10)  0.189   
Hypertension  25 (7.42)  18 (6.29)  7 (13.73)  0.806  2.37 (0.93–6.04) 
Dyslipidemia  11 (3.26)  8 (2.80)  3 (5.88)  0.253  2.17 (0.55–8.52) 
Charlson comorbidity score (median, range)  0.60 (0–8)  0.59 (0–8)  0.63 (0–6)  0.843   
Anemia  67 (19.88)  50 (17.48)  17 (33.33)  0.009  2.36 (1.21–4.59) 
Other comorbidities  30 (8.90)  23 (8.04)  7 (13.73)  0.189  1.81 (0.73–4.51) 
Previous abdominal surgery  81 (24.04)  70 (24.48)  11 (21.57)  0.654  0.85 (0.41–1.74) 
Time from diagnosis to surgery (months, median, range)  63.36 (0–504)  62.14 (0–300)  70.18 (0–504)  0.475   
Character of surgery (Urgent)  83 (24.63)  64 (22.38)  19 (37.25)  0.023  2.06 (1.09–3.90) 
Luminal vs. complicated disease (Complicated)  277 (82.20)  230 (80.42)  47 (92.16)  0.044  2.86 (0.98–8.34) 
Montreal classification
A1  21 (6.23)  20 (6.99)  1 (1.96)  0.171  0.27 (0.03–2.04) 
A2  235 (69.73)  197 (68.88)  38 (74.51)  0.420  1.32 (0.67–2.60) 
A3  81 (24.04)  69 (24.13)  12 (23.53)  0.927  0.97 (0.48–1.95) 
B1  60 (17.80)  56 (19.58)  4 (7.84)  0.044  0.35 (0.12–1.02) 
B2  155 (45.99)  131 (45.80)  24 (47.06)  0.868  1.05 (0.58–1.91) 
B3  101 (29.97)  84 (29.37)  17 (33.33)  0.569  1.20 (0.64–2.27) 
B2-3  21 (6.23)  15 (5.24)  6 (11.76)  0.076  2.41 (0.88–6.58) 
Perianal CD  93 (27.60)  81 (28.32)  12 (23.53)  0.481  0.78 (0.39–1.56) 
Previous steroids  128 (37.98)  105 (36.71)  23 (45.10)  0.256  1.42 (0.77–2.59) 
Previous exposure to biological agents  180 (53.41)  153 (53.50)  27 (52.94)  0.942  0.98 (0.54–1.78) 
Number of previous biologics
114 (63.33)  95 (33.22)  19 (37.25)  0.574  1.19 (0.64–2.22) 
58 (32.22)  52 (18.18)  6 (11.76)  0.263  0.60 (0.24–1.49) 
8 (4.44)  6 (2.10)  2 (3.92)  0.431  1.90 (0.37–9.75) 
Exposure to biologics within 12 weeks before surgery  115 (63.89)  98 (64.05)  17 (62.96)  0.913  0.95 (0.41–2.23) 
Requirement of preoperative nutritional optimization  50 (14.84)  40 (13.99)  10 (19.61)  0.298  1.50 (0.69–3.24) 
Albumin level (median, range)  3.48 (1.2–5.2)  3.54 (1.9–5.2)  3.23 (1.2–4.5)  0.04   
ASA score
62 (18.40)  55 (19.23)  7 (13.73)  0.350  0.67 (0.28–1.57) 
II  239 (70.92)  202 (70.63)  37 (72.55)  0.781  1.10 (0.56–2.14) 
III  34 (10.09)  27 (9.44)  7 (13.73)  0.349  1.53 (0.62–3.72) 
IV  2 (0.59)  2 (0.70)  0.549  0.000 

Univariate comparative analysis of preoperative characteristics between groups. Categorical variables described as percentages whereas numerical variables were described as mean or median (accordingly) with their range. Normality of each numerical variable was evaluated visually and with the Kolmogorov–Smirnov test. Chi square or Fisher exact tests, as appropriate, for the comparison of categorical variables, and the Student's T or Fisher's exact test for continuous variables. OR with respective 95% CI also calculated.

An additional analysis stratifying time from diagnosis to surgery into three categories (less than 2 years, 2–5 years, and more than 5 years) was performed, which also did not show differences between groups.

On the other hand, POC patients presented higher rates of smoking (31.37 vs. 17.83%, p=0.026, OR: 2.11), preoperative anemia (33.33 vs. 17.48, p=0.009, OR: 2.36), and operations in an urgent setting (37.25 vs. 22.38%, p=0.023, OR: 2.06). Operations for complicated disease (when compared to luminal phenotype) were also more frequent in the POC group. Albumin levels were lower in the POC group (3.23 vs. 3.54, p=0.04). The rate of exposure to steroids at the time of surgery was numerically higher in the POC group, but this difference was not statistically significant (45.10 vs. 36.71%, p=0.256). Previous perianal CD, previous use of biological agents, exposure to these drugs within 3 months of surgery, and requirements of preoperative nutritional optimization were similar in POC and NPOC patients. Lastly, no difference was seen as regards exposure to different types of biologic agents and the presence of complications.

Intraoperative variables

Intraoperative information is described in detail in Table 2.

Table 2.

Intraoperative variables.

Variables  All patientsN=337 (100%)  NPOCN=286 (84.87%)  POCN=51 (15.13%)  p value  OR (95% CI) 
Operative time (median, range)  151.43 (45–420)  143.86 (45–360)  188.77 (60–420)  0.005   
Approach
Laparoscopic  173 (51.34)  148 (51.75)  25 (49.02)  0.719  0.90 (0.49–1.63) 
Conventional  164 (48.66)  138 (48.25)  26 (50.98)  0.719  1.11 (0.61–2.03) 
Conversion rate  18/173 (10.40)  14/148 (9.46)  4/25 (16)  0.322  1.82 (0.54–6.11) 
Requirement of associated procedures  53 (15.73)  41 (14.34)  12 (23.53)  0.097  1.84 (0.89–3.82) 
Intraoperative complications  22 (6.53)  13 (4.55)  9 (17.65)  0.000  4.50 (1.78–11.38) 
CLASSIC minor  19/22 (86.36)  13/22 (100)  6/9 (66.67)  0.025   
CLASSIC major  3/22 (13.64)  3/9 (33.33)  0.025   
Primary anastomosis  310 (91.99)  268 (93.71)  42 (82.35)  0.006  0.31 (0.13–0.75) 
Type of anastomosis
Hand-sewn  47/310 (15.16)  38/268 (14.18)  9/42 (21.43)  0.223  1.81 (0.82–4.03) 
Stapled  263/310 (84.84)  230/268 (85.82)  33/42 (78.57)  0.223  0.61 (0.27–1.37) 
Hand-sewn
One layer  23/47 (48.94)  18/38 (47.37)  5/9 (55.56)  0.882  1.11 (0.27–4.54) 
Two-layer  24/47 (51.06)  20/38 (52.63)  4/9 (44.44)  0.477  0.60 (0.24–2.53) 
Anastomotic configuration
End-to-end  28/310 (9.03)  25/268 (9.33)  3/42 (7.14)  0.646  0.96 (0.31–3.00) 
End-to-side  30/310 (9.68)  27/268 (10.07)  3/42 (7.14)  0.550  0.96 (0.31–3.00) 
Side-to-side  252/310 (81.29)  216/268 (80.60)  36/42 (85.71)  0.429  1.44 (0.58–3.62) 
Anastomotic orientation
Isoperistaltic  57/310 (18.39)  51/268 (19.03)  6/42 (14.29)  0.461  1.41 (0.56–3.53) 
Anti-peristaltic  253/310 (81.61)  217/268 (80.97)  36/42 (85.71)  0.461  0.82 (0.34–1.96) 
Decision after resection
Anastomosis w/o diversion  292 (86.65)  252 (88.11)  40 (78.43)  0.061  0.49 (0.23–1.05) 
Diverted anastomosis  18 (5.34)  15 (5.24)  3 (5.88)  0.852  1.13 (0.31–4.06) 
End ileostomy, intra abdominal stump  7 (2.08)  5 (1.75)  2 (3.92)  0.316  2.29 (0.43–12/22) 
End ileostomy, subcutaneous stump  13 (3.86)  11 (3.85)  2 (3.92)  0.979  1.02 (0.22–4.76) 
End ileostomy, mucous fistula  7 (2.08)  3 (1.05)  4 (7.84)  0.002  8.03 (1.70–37.96) 
Postoperative antibiotics  169 (50.15)  130 (45.45)  39 (76.47)  0.000  3.90 (1.92–7.90) 

Univariate comparative analysis of intraoperative characteristics between groups. Categorical variables described as percentages whereas numerical variables were described as mean or median (accordingly) with their range. Normality of each numerical variable was evaluated visually and with the Kolmogorov–Smirnov test. Chi square or Fisher exact tests, as appropriate, for the comparison of categorical variables, and the Student's T or Fisher's exact test for continuous variables. OR with respective 95% CI also calculated.

Patients from the POC group had a significantly longer operative time (188.77 vs. 143.86%, p=0.005), numerically higher rates of associated procedures (23.53 vs. 14.34%, p=0.097) and intraoperative complications (17.65 vs. 4.55, p<0.001). On the contrary, patients in the NPOC group presented a higher proportion of primary anastomosis (93.71 vs. 82.35, p=0.006) and lower need for postoperative antibiotics (45.45 vs. 76.47, p<0.001, OR: 3.90).

The overall proportion of minimally invasive surgery was 51.34%, with no difference between the groups in terms of initial laparoscopic approach. Even though conversion rates were numerically higher in the POC group, the difference was not significant (16 vs. 9.46%, p=0.322). Different types of anastomoses were included in the analysis. Side-to-side, anti-peristaltic stapled anastomosis was the most common anastomotic configuration. No differences were identified between the groups regarding the specific type of anastomosis. Lastly, regarding management of the colonic stump in patients without primary anastomosis, POC patients presented a higher proportion of ileostomy and colonic mucous fistula.

Postoperative outcomes

Postoperative variables are detailed in Table 3. Patients from the POC group had significantly longer hospitalization stay (19.54 vs. 5.48 days, p<0.001), higher rates of readmissions to hospital (35.29 vs. 4.20, p<0.001), reoperations (66.67 vs. 1.75, p<0.001) and mortality (7.84 vs. 0, p<0.001) within 30 days of the index operation.

Table 3.

Postoperative variables.

Variables  All patientsN=337 (100%)  NPOCN=286 (84.87%)  POCN=51 (15.13%)  p value  OR (95% CI) 
Hospitalization length in days (median, 95% CI)  8.03 (2–81)  6.01 (2–35)  19.54 (6–81)  0.000   
Readmission to hospital  30 (8.90)  12 (4.20)  18 (35.29)  0.000  12.45 (5.13–30.23) 
Reoperation  39 (11.57)  5 (1.75)  34 (66.67)  0.000  112.40 (23.98–526.85) 
Mortality  4 (1.19)  4 (7.84)  0.000   

Univariate comparative analysis of postoperative characteristics between groups. Categorical variables described as percentages whereas numerical variables were described as mean or median (accordingly) with their range. Normality of each numerical variable was evaluated visually and with the Kolmogorov–Smirnov test. Chi square or Fisher exact tests, as appropriate, for the comparison of categorical variables, and the Student's T or Fisher's exact test for continuous variables. OR with respective 95% CI also calculated.

16 patients (5.16%) presented an anastomotic leakage after surgery, and most of them required a reoperation.

Multivariate analysis

Table 4 described the results of multivariable analysis. Smoking (OR=2.99, p=0.040) and intraoperative complications (OR=8.43, p=0.034) were independently associated with the occurrence of postoperative major complications.

Table 4.

Multivariate analysis.

Variables  OR  Standard Error  p value  95% CI 
Smoking  2.99  1.605  0.040  1.05–8.56 
Preoperative anemia  1.43  0.710  0.476  0.54–3.79 
Urgency setting  0.69  0.377  0.497  0.236–2.015 
Surgery for complications of the disease  1.69  1.455  0.544  0.31–9.15 
Preoperative albumin level  0.57  0.205  0.120  0.29–1.16 
Operative time  1.00  0.002  0.236  0.99–1.01 
Intraoperative complications  8.43  8.472  0.034  1.18–60.44 
Primary anastomosis  1.08  0.626  0.895  0.35–3.37 
Need for postoperative antibiotics  1.08  0.626  0.895  0.35–3.37 

Multivariable analysis using a logistic regression model including all the variables compared with a p value of less than 0.05 and those variables considered clinically significant by the investigators. A p value below 0.05 was considered statistically significant, using postoperative major complications as dependent variable.

Discussion

The present study presents a large group of patients operated for primary ileocaecal CD and comprises one of the first international multicentric experiences regarding surgical treatment of CD patients from different countries of Latin America. In multivariable analysis, smoking and intraoperative complications were independently associated with higher rates of postoperative morbidity.

Since postoperative morbidity after resections still represents one of the major problems in the management of CD (especially when compared to other intestinal problems),13 several studies have been published in recent years, aiming to determine specific factors which could possibly affect postoperative outcomes. Some risk factors for major complications have been extensively described, as smoking,14 preoperative anemia,15,16 urgent procedures,14,17 penetrating disease,5,15,17–20 hypoalbuminemia20–22 and previous exposure to steroids.14,18,19,23 Our study presented similar findings in univariate analysis, as smoking, preoperative anemia, urgent surgery and complicated disease (stenotic or penetrating) were more frequently observed in patients with postoperative complications.

On the other hand, previous exposure to biological agents has been subjected to an endless debate as to its relation (or not) to worse postoperative outcomes. Despite some studies identifying a correlation between preoperative anti-TNF agents and higher rate of postoperative complications,16,23–25 a large meta-analysis including information of 18 non-randomized studies failed to find an association between Infliximab and overall complications.27 Furthermore, the prospective multicentric PUCCINI trial28 evaluated postoperative morbidity in IBD patients exposed to biologics and also did not demonstrate an association between these drugs and worse postoperative outcomes. Overall infections (18.1% vs 20.2%, p=0.469) and surgical site infections (12.0% vs 12.6%, p=0.889) rates were similar in patients previously exposed to anti-TNF agents and those unexposed. In multivariable analysis, current exposure to these agents was not associated with overall infections (OR, 1.050; 95% CI, 0.716–1.535) or surgical site infection (OR, 1.249; 95% CI, 0.793–1.960). Detectable concentrations of anti-TNF agents were not associated with infectious complications. In our study, preoperative exposure to biologics was observed in 52.94% of patients with postoperative major complications and 53.5% of those without morbidity (p=0.942), findings which are compatible with most retrospective studies and the prospective aforementioned PUCCINI trial. Guidelines still do not present specific formal recommendations regarding preoperative use of biologics,29 and more cause-effect relationship studies are warranted.

Few studies have investigated intraoperative factors in ileocaecal resections due to CD and their possible relation to postoperative complications. Our study identified that prolonged operative time and intraoperative complications negatively impacted postoperative morbidity, whereas receiving a primary anastomosis seemed to work as a protective factor. A possible reason for this finding is that surgeons, facing patients in worse conditions or requiring more complex procedures, could be less eager to perform a primary anastomosis (selection bias). Postoperative antibiotics were also more needed in patients with complications, which could be partially explained by the fact that this group faced more complex surgery, with longer operative time and more complicated disease.

In our study, the presence of postoperative major complications had a major impact in other postoperative indicators, including requirements of prolonged hospitalization and higher rates of reoperations, readmissions as well as mortality. This highlights the interest in defining preoperative risk factors for these events, with special interest in modifiable characteristics, such as smoking or delayed surgical indication.

Since this is one of the first multicentric Latin American studies looking into surgical treatment of CD patients, it is interesting to have a snapshot of operative characteristics. Initially, the overall 51% rate of laparoscopic procedures seems low in the minimally invasive surgery era. However, when looking at other studies, one can observe that the proportion of laparoscopic cases in these publications is below 60%.5,14–26,30 This could be due to the fact that the main indication for surgery in patients with CD is still represented by disease complications, such as long fibrotic stenosis, internal or external fistulas, and inflammatory masses which can limit decision toward a laparoscopic surgical approach.

Overall, the rate of primary anastomosis was high in our cohort of patients, and the most common type and configuration of the performed anastomoses (stapled, side-to-side) was compatible with what is suggested by international guidelines.29 Even though there is no consensus on the management of the colonic stump when a primary anastomosis is not performed, the tendency for exteriorization as a double-loop stoma or mucous fistula instead of an intra-abdominal stump which was observed in patients with complications can be explained by the fact that patients in poor general condition might be at risk of colonic stump leakages and consequent septic complications.

Our study is associated with some inherent limitations, such as its retrospective nature and the low number of patients with complications. Furthermore, practices may vary between the centers, and the surgeons’ experience and expertise were not evaluated in detail (some cases could be performed by junior, others by senior staff members, and some by residents under assistance). Minimally invasive resections were performed in 60% of cases, which reflects the reality of our continent in colorectal surgery in general. We also did not carry out possible differences between centers, as some centers included less patients than others and this was not the main purpose of our analysis. Groups were also not considered fully homogeneous, as some variables differed between patients with and without associated morbidity. Another limitation is that no specific sample calculation was possible, and we worked with a convenience sample.

On the other hand, the present study's main strength is that it represents the very first solid international multicentric analysis of postoperative outcomes from Latin America, which may assist in surgical management of CD in our continent.

In summary, smoking and the presence of intraoperative complications were identified as predictors of postoperative major complications after ileocaecal resections in CD and may have an important impact in different postoperative indicators. This international study focuses efforts in gathering more experience in the surgical management of CD in Latin America. More prospective research aiming identification of preoperative risk factors for postoperative complications is warranted, in order to properly optimize patients for ileocaecal resections in our region.

Funding

This study has not been funded.

Conflict of interest

The authors declare no conflict of interest.

Appendix A
Supplementary data

The following are the supplementary data to this article:

References
[1]
R. Thoreson, J. Cullen.
Pathophysiology of inflammatory bowel disease: an overview.
Surg Clin North Am, 87 (2007), pp. 575-585
[2]
C. Rungoe, E. Langholz, M. Andersson, S. Basit, N.M. Nielsen, J. Wohlfahrt, et al.
Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011.
[3]
P. Kotze, F.E. Underwood, A.O. Mourao, J.G.P. Ferraz, R. Saad-Hossne, M. Toro, et al.
Progression of inflammatory bowel diseases throughout Latin America and the Caribbean: a systematic review.
Clin Gastroenterol Hepatol, 18 (2020), pp. 304-312
[4]
P. Kirchhoff, P.A. Clavien, D. Hahnloser.
Complications in colorectal surgery: risk factors and preventive strategies.
Patient Saf Surg, 4 (2010), pp. 5
[5]
F. Bellolio, Z. Cohen, H.M. Macrae, B.I. O’Connor, H. Huang, J.C. Victor, et al.
Outcomes following surgery for perforating Crohn's disease.
Br J Surg, 100 (2013), pp. 1344-1348
[6]
R.G. Farmer, W.A. Hawk, R.B. Turnbull.
Indications for surgery in Crohn's disease: analysis of 500 cases.
Gastroenterology, 71 (1976), pp. 245-250
[7]
J. Yamamoto-Furusho, N. Parra-Holguin, F. Juliao-Baños, F. Puentes, R. López, F. Bosques-Padilla, et al.
Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean.
Medicine (Baltimore), 101 (2022), pp. e28624
[8]
Surgical IBD LATAM Consortium.
Earlier surgery is associated to reduced postoperative morbidity in ileocaecal Crohn's disease: results from SURGICROHN – LATAM study.
[9]
D. Dindo, N. Demartines, P.A. Clavien.
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
[10]
W.A. Bemelman, J. Warusavitarne, G.M. Sampietro, Z. Serclova, O. Zmora, G. Luglio, et al.
ECCO-ESCP consensus on surgery for Crohn's Disease.
J Crohns Colitis, 12 (2018), pp. 1-16
[11]
B.Y. Maruyama, C. Ma, R. Panaccione, P.G. Kotze.
Early laparoscopic ileal resection for localized ileocaecal Crohn's disease: hard sell or a revolutionary new norm?.
Inflamm Intest Dis, 7 (2022), pp. 13-20
[12]
R. Rosenthal, H. Hoffmann, P.A. Clavien, H.C. Bucher, S. Dell-Kuster.
Definition and Classification of Intraoperative Complications (CLASSIC): Delphi study and pilot evaluation.
World J Surg, 39 (2015), pp. 1663-1671
[13]
D.W. Larson, M.A. Abd El Aziz, W. Perry, K.T. Behm, S. Shawki, J. Mandrekar, et al.
Surgical resection for Crohn's and cancer: a comparison of disease-specific risk factors and outcomes.
Dig Surg, 38 (2021), pp. 120-127
[14]
P.M. Neary, A.C. Aiello, L. Stocchi, S. Shawki, T. Hull, S.R. Steele, et al.
High-risk ileocolic anastomoses for Crohn's disease: when is diversion indicated?.
J Crohn's Colitis, 13 (2019), pp. 856-863
[15]
T. Yamamoto, A. Spinelli, Y. Suzuki, R. Saad-Hossne, F.V. Teixeira, I. Carvalho de Albuquerque, et al.
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: a retrospective international multicentre study.
Unit Eur Gastroenterol J, 4 (2016), pp. 784-793
[16]
A. Brouquet, L. Maggiori, P. Zerbib, J.H. Lefevre, Q. Denost, A. Germain, et al.
Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic crohn disease.
Ann Surg, 267 (2018), pp. 221-228
[17]
A. Gutierrez, M. Rivero, M.D. Martín-Arranz, V. García Sánchez, M. Castro, J. Barrio, et al.
Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn's disease: analysis from the PRACTICROHN study.
Gastroenterol Rep, 7 (2019), pp. 168-175
[18]
A. Alves, Y. Panis, P. Valleur, M. Pocard, E. Vicaut, P. Valleur.
Risk factors for intra-abdominal septic complications after a first ileocaecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients.
Dis Colon Rectum, 50 (2006), pp. 331-336
[19]
A. Tzivanakis, J.C. Singh, R.J. Guy, S. Travis, N.J. Mortensen, B.D. George.
Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
Dis Colon Rectum, 55 (2012), pp. 558-562
[20]
C. Galata, C. Weiss, J. Hardt, S. Seyfried, S. Post, P. Kienle, et al.
Risk factors for early postoperative complications and length of hospital stay in ileocaecal resection and right hemicolectomy for Crohn's disease: a single-center experience.
Int J Colorectal Dis, 33 (2018), pp. 937-945
[21]
X. Ge, H. Liu, S. Tang, Y. Wu, Y. Pan, W. Liu, et al.
Preoperative hypoalbuminemia is an independent risk factor for T postoperative complications in Crohn's disease patients with normal BMI: a cohort study.
Int J Surg, 79 (2020), pp. 294-299
[22]
R.S. Shah, S. Bachour, X. Jia, S.D. Holubar, T.L. Hull, J-P. Achkar, et al.
Hypoalbuminaemia, not biologic exposure, is associated with postoperative complications in Crohn's disease patients undergoing ileocolic resection.
J Crohn's Colitis, 15 (2021), pp. 1142-1151
[23]
M. Fumery, P. Seksik, C. Auzolle, N. Munoz-Bongrand, J-M. Gornet, G. Boschetti, et al.
Postoperative complications after ileocaecal resection in Crohn's disease: a prospective study from the REMIND group.
Am J Gastroenterol, 112 (2017), pp. 337-345
[24]
O.S. Morar, J.D. Hodgkinson, S. Thalayasingam, K. Koysombat, M. Purcell, A.L. Hart, et al.
Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn's disease—considerations in pre-operative and perioperative optimisation techniques to improve outcome.
J Crohn's Colitis, 9 (2015), pp. 483-491
[25]
A. de Buck van Overstraeten, E.J. Eshuis, S. Vermeire, G. Van Assche, M. Ferrante, G.R. D’Haens, et al.
Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centers.
Br J Surg, 104 (2017), pp. 1713-1722
[26]
I. Jouvin, J. Lefevre, B. Creavin, S. Pitel, N. Chafai, E. Tiret, et al.
Postoperative morbidity risks following ileocolic resection for Crohn's disease treated with anti-TNF alpha therapy: a retrospective study of 360 patients.
Inflamm Bowel Dis, 24 (2018), pp. 422-432
[27]
Y. Xu, L. Yang, P. An, B. Zhou, G. Liu.
Meta-analysis: the influence of preoperative infliximab use on postoperative complications of Crohn's disease.
Inflamm Bowel Dis, 25 (2019), pp. 261-269
[28]
B. Cohen, P. Fleshner, S. Kane.
Anti-tumor necrosis factor is not associated with postoperative infections: results from prospective cohort of ulcerative colitis and Crohn's disease patients undergoing surgery to identify risk factors for postoperative infections (PUCCINI).
Gastroenterology, 156 (2019),
[29]
M. Adamina, S. Bonovas, T. Raine, A. Spinelli, J. Warusavitarne, A. Armuzzi, et al.
ECCO guidelines on therapeutics in Crohn's disease: surgical treatment.
J Crohn's Colitis, 14 (2020), pp. 155-168
[30]
O. Shental, H. Tulchinsky, R. Greenberg, J.M. Klausner, S. Avital.
Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
Dis Colon Rectum, 55 (2012), pp. 1125-1130
Copyright © 2023. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos